Most Inflammatory, Cardiac Manifestations of MIS-C Resolve
Most inflammatory markers normalized by one to four weeks; however, elevated double-negative T cells seen in 92 percent at one to four months
Effectiveness Similar for First-Line ACE Inhibitors, ARBs in HTN
Risks for angioedema, cough, pancreatitis, and GI bleeding significantly lower with ARBs for first-line HTN treatment
Medical Groups Call for Mandatory COVID-19 Vaccination for Health Care Workers
Mandatory vaccination is especially crucial to protect vulnerable people, including unvaccinated children and those with weakened immune systems
Risk Factors ID’d for VTE, ASCVD in Rheumatoid Arthritis Patients
Risk for atherosclerotic cardiovascular disease increased twofold after unprovoked VTE in rheumatoid arthritis
Disparities Seen for Racial, Ethnic Minorities in Outpatient Practices
Visit rates lower for Black individuals versus Whites for 23 of 29 specialties, with marked disparities for dermatology, otolaryngology, general surgery
Even Limited Breastfeeding May Lower Child Blood Pressure
No significant dose-response association seen for breastfed children according to duration or exclusivity of breastfeeding
Increasing Physical Activity After ICD Implantation May Cut Deaths
Risk for mortality reduced with increased physical activity, regardless of participation in cardiac rehabilitation
2019 to 2020 Saw 1.5-Year Decline in U.S. Life Expectancy at Birth
Mortality due to COVID-19 had biggest effect on decline in life expectancy for both men and women, all races examined
Prior Statin Use Linked to Reduced Risk for Death in COVID-19
Risk for death significantly reduced with prior statin and/or antihypertensive use among those with history of CVD and/or hypertension
No Increase in Risk With Dapagliflozin in Patients With Stage 4 CKD
Prespecified analysis of RCT shows reduced risk with dapagliflozin versus placebo for composite outcome that included kidney, CV events
